CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Blend (9mg)
$86.00 $41.00
Peptide Blend: CJC-1295, Ipamorelin, & GHRP-2
This product is a 9mg blend of three high-purity peptides: CJC-1295 NO DAC (3mg), Ipamorelin (3mg), and GHRP-2 (3mg). It is provided in a lyophilized powder form with a purity of >99% for research purposes. The SKU is P-CJCIPAMGHR2-9.
Pricing and Discounts:
5-8 units: A 5% discount is applied, with a price of $76.95 per unit.
9+ units: A 10% discount is applied, with a price of $72.90 per unit.
We also offer FREE shipping on all orders over $200.
CJC-1295 (Mod GRF 1-29), Ipamorelin, & GHRP-2 Peptide Blend: A Focus on Growth Hormone Modulation π¬
What is this Peptide Blend?
This blend combines three synthetic peptides: CJC-1295 (Mod GRF 1-29), Ipamorelin, and GHRP-2. All three are researched for their potential to stimulate the release of growth hormone (GH).
CJC-1295 (Mod GRF 1-29) is an analog of Growth Hormone-Releasing Hormone (GHRH), which acts as an agonist for GHRH receptors. It is modified with a drug affinity complex (DAC) element to potentially enhance its stability and longevity.
Ipamorelin is a pentapeptide that mimics ghrelin (the hunger hormone) and acts on the Growth Hormone Secretagogue receptors (GHS-R1a) in the pituitary gland.
GHRP-2 is a hexapeptide that also acts on the GHS-R1a receptors, similar to Ipamorelin. Both Ipamorelin and GHRP-2 are classified as Growth Hormone Secretagogues (GHSs).
When combined, these peptides are anecdotally reported to exhibit synergistic action, potentially providing a more robust stimulus for GH release.
Key Areas of Scientific Research π§ͺ
1. Peptide Blend and Growth Hormone Deficiencies
Research on individuals with GH deficiencies suggests that these peptides may stimulate GH release by acting on the pituitary gland or the hypothalamus. The peptides appeared to cause a gradual and sustained rise in GH concentration. Studies like these are still ongoing, but preliminary findings suggest that they are well-tolerated and can stimulate GH secretion.
2. Peptide Blend and Food Intake
Research indicates that Ipamorelin and GHRP-2 may have a synergistic effect on increasing appetite, which is linked to their agonistic action on ghrelin receptors. A study on GHRP-2 found that subjects ate approximately 36% more than a control group, with a corresponding increase in GH levels. Another study suggested that Ipamorelin may have contributed to a 15% rise in body weight and an increase in fat mass, potentially by elevating food consumption and serum leptin levels. In contrast, CJC-1295 (Mod GRF 1-29) has not been suggested to affect appetite.
3. Peptide Blend and Bone Mass
By increasing GH synthesis, all three peptides may potentially upregulate bone mineral density (BMD). Research on Ipamorelin in murine models showed a potential increase in tibial and vertebral bone mineral content. Although the overall BMD did not appear to change, the increase in bone mineral content was attributed to an increase in cross-sectional bone area, suggesting a potential role in promoting bone growth and dimension.
4. Peptide Blend and Muscle Mass
Research suggests that CJC-1295 (Mod GRF 1-29) may have favorable actions on lean mass. In murine models with a GHRH gene deletion, the peptide appeared to help them retain typical lean weight and length. It may also increase the number of somatotroph cells in the pituitary gland, which are responsible for generating growth hormone. Ipamorelin has also been proposed to increase lean mass, with some preliminary studies suggesting it may lead to a positive nitrogen balance.
Product Specifications π
Molecular Formula:
CJC-1295 (Mod GRF 1-29): C152βH252βN44βO42β
Ipamorelin: C38βH49βN9βO5β
GHRP-2: C45βH55βN9βO6β
Molecular Weight:
CJC-1295 (Mod GRF 1-29): 3367.9 g/mol
Ipamorelin: 711.9 g/mol
GHRP-2: 817.9 g/mol
Other Known Titles:
Ipamorelin: Ipamorelin Acetate, IPA
GHRP-2: Pralmorelin, Growth hormone-releasing peptide-2
Important Notice: The CJC-1295 (Mod GRF 1-29) & Ipamorelin & GHRP-2 Peptide Blend is available for research and laboratory purposes only. It is not intended for human or veterinary use. All information provided is for educational and scientific reference only and has not been evaluated by the FDA or any medical regulatory body.